EVLO (Evelo Biosciences) Institutional Ownership: 0.14% (As of Jul. 08, 2026)


What is Evelo Biosciences Institutional Ownership?

Evelo Biosciences EVLO Institutional Ownership is 0.14% as of Jul. 08, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Evelo Biosciences's institutional ownership is 0.14%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Evelo Biosciences's Insider Ownership is 2.81%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Evelo Biosciences's Float Percentage Of Total Shares Outstanding is 46.68%.

Evelo Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Evelo Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evelo Biosciences Institutional Ownership Chart

Evelo Biosciences Historical Data

The historical data trend for Evelo Biosciences can be seen below:

2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31
Institutional Ownership 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13

Evelo Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.14% mean?
Evelo Biosciences (EVLO) has a Institutional Ownership of 0.14% as of Jul. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Evelo Biosciences and its competitors.
Is Evelo Biosciences' Institutional Ownership too high?
Evelo Biosciences' current Institutional Ownership is 0.14%.
How does Evelo Biosciences' Institutional Ownership compare to IMNN and EDSA?
Evelo Biosciences' Institutional Ownership of 0.14% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Evelo Biosciences and its competitors. Evelo Biosciences's current Institutional Ownership is 0.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current Institutional Ownership of 0.14%. The current Institutional Ownership is 0.14%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current Institutional Ownership is 0.14% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.